SHL Telemedicine confirms discussions regarding a possible merger or takeover transaction relating to the company

Tel Aviv / Zurich, 21 January 2020 – Following an article published in the Israeli financial press this morning, SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL”), a leading provider…

Continue ReadingSHL Telemedicine confirms discussions regarding a possible merger or takeover transaction relating to the company
  • Post category:
  • Post comments:0 Comments

Procedural decision of the Swiss Takeover Board on the status of the proceedings concerning the outstanding mandatory offer to the shareholders of SHL Telemedicine Ltd.

Tel Aviv / Zurich, 6 November 2019 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) ("SHL"), a leading provider and developer of advanced personal telemedicine solutions, announced today that the…

Continue ReadingProcedural decision of the Swiss Takeover Board on the status of the proceedings concerning the outstanding mandatory offer to the shareholders of SHL Telemedicine Ltd.
  • Post category:
  • Post comments:0 Comments

SHL Telemedicine expands to The Netherlands and signs an agreement to acquire Kadima BV / 24CARE Inkoop BV

Tel Aviv / Zurich, August 28, 2019 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) ("SHL”), a leading provider and developer of advanced personal telemedicine solutions, announced today that that…

Continue ReadingSHL Telemedicine expands to The Netherlands and signs an agreement to acquire Kadima BV / 24CARE Inkoop BV
  • Post category:
  • Post comments:0 Comments

Swiss Takeover Board concluded that the closing of a potential reverse triangular merger with a minimum price per share of CHF 7.70 shall be considered as a fulfillment of the obligation to launch a tender offer at the same price per share

Tel Aviv / Zurich, July, 12, 2019 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL”), a leading provider and developer of advanced personal telemedicine solutions, announced today that the…

Continue ReadingSwiss Takeover Board concluded that the closing of a potential reverse triangular merger with a minimum price per share of CHF 7.70 shall be considered as a fulfillment of the obligation to launch a tender offer at the same price per share
  • Post category:
  • Post comments:0 Comments